Upcoming Event: Generics & Biosimilars Asia 2011
11/29/2010
Event: Generics & Biosimilars Asia 2011
Dates: March 3 - 4, 2011
Venue: Amara Hotel, Singapore
Tel: +65 6722 9388
The global generics market is forecast to be valued at US$183.2 billion by 2014, with Asia Pacific accounting for 36.2% of the global generics market.
With strong demand for affordable healthcare throughout Asia governments are favoring the production and prescription of generics and biosimilars. The Generics & Biosimilars Asia 2011 conference is set to address many of the pressing issues faced by both innovator and generic drug companies. Attendees will be able to network and learn from peers facing similar challenges in market access, drug pricing and reimbursement in the evolving pharmaceutical industry in Asia.
Key themes for Generics & Biosimilars 2011:
- Latest development of regulatory guidelines for the registration of generics and biosimilars in Asia and
Europe;
- Evaluating how reimbursement policies can affect your drug pricing strategies;
- Examining how strategic alliances affect R&D, innovation and market positioning of your products;
- The key challenges in marketing and distributing innovative drugs alongside generics in Asia;
- Overcoming the challenges of the biosimilars industry; and
- Pharmacovigilance for generics and biosimilars: how can consumers’ health be safeguarded?